ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 76 out of 761

$635K Total Retail Price of All Prescriptions

Rank: 60 out of 761

662 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 662 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 662 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 8,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 458 411 1 3
HYDROCODONE-ACETAMINOPHEN 412 293 S3 2 5
OMEPRAZOLE 381 304 3 4
AMLODIPINE BESYLATE 320 275 4 6
LISINOPRIL 281 247 5 1
GABAPENTIN 278 162 6 15
SIMVASTATIN 224 194 7 2
ZOLPIDEM TARTRATE 213 150 8 22
MORPHINE SULFATE ER 201 65 S2 9 38
PRAVASTATIN SODIUM 169 152 10 20
METOPROLOL SUCCINATE 167 145 11 16
MELOXICAM 167 133 11 61
FUROSEMIDE 164 140 13 7
LOSARTAN POTASSIUM 160 156 14 13
ATENOLOL 153 147 15 8
ALENDRONATE SODIUM 146 118 16 21
POLYETHYLENE GLYCOL 3350 138 124 17 62
SERTRALINE HCL 134 123 18 25
CYMBALTA 132 57 19 53
CARVEDILOL 130 119 20 26
LOVASTATIN 129 73 21 17
TRAZODONE HCL 129 96 21 23
ATORVASTATIN CALCIUM 127 102 23 12
METFORMIN HCL ER 125 103 24 67
OXYCODONE HCL 122 36 S2 25 24
CITALOPRAM HBR 121 97 26 19
POTASSIUM CHLORIDE 120 100 27 18
METFORMIN HCL 109 89 28 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 104 80 29 35
FLUTICASONE PROPIONATE 96 74 30 29
PANTOPRAZOLE SODIUM 95 72 31 40
WARFARIN SODIUM 91 74 32 9
NORTRIPTYLINE HCL 85 42 33 101
CYCLOBENZAPRINE HCL 83 35 R 34 51
ROPINIROLE HCL 82 32 35 95
TAMSULOSIN HCL 79 76 36 27
PREDNISONE 79 46 36 30
CRESTOR 71 60 38 36
OXYCODONE HCL-ACETAMINOPHEN 70 32 S2 39 136
SPIRONOLACTONE 69 63 40 45
FENTANYL 66 22 S2 41 57
METHADONE HCL 66 0 S2 41 75
METHOCARBAMOL 65 31 R 43 172
FLUOXETINE HCL 63 38 44 31
TRIAMTERENE-HCTZ 63 52 44 42
NEXIUM 62 29 46 98
TIZANIDINE HCL 59 15 47 139
METOPROLOL TARTRATE 58 56 48 14
LOSARTAN-HYDROCHLOROTHIAZIDE 57 56 49 65
ADVAIR DISKUS 55 46 50 37
OXYCODONE-ACETAMINOPHEN 55 42 S2 50 49
QUETIAPINE FUMARATE 54 43 52 90
FINASTERIDE 53 44 53 73
LYRICA 53 17 53 134
PROMETHAZINE HCL 51 17 R 55 104
CIPROFLOXACIN HCL 50 46 56 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.